Perforated colonic diverticular disease: the importance of NSAIDs, opioids, corticosteroids, and calcium channel blockers

Original Article
First Online:
Accepted:

Abstract

Purpose

Perforated colonic diverticular disease is associated with a high rate of late sequel and mortality. The risk of colonic perforation may relate to intracolonic pressure and mucosal barrier function in the wall of diverticula. The use of substances affecting these parameters may therefore be associated with the risk of developing a perforation. The aim was to study the effect of nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, corticosteroids, calcium channel blockers, and antimuscarinics on perforation in diverticular disease.

Materials and methods

A review of 54 patients with colonic diverticular perforation—forming the case group—and 183 patients with verified colonic diverticular disease—forming the control group—was done. Patient characteristics and drug use was registered.

Results

Case group and control group were comparable with respect to sex, age, and comorbidity. In multivariate analysis, the use of NSAIDs (OR 3.56; 95% CI 1.50–8.43), opioids (OR 4.51; 95% CI 1.67–12.18), and corticosteroids (OR 28.28; 95% CI 4.83–165.7) were significantly associated with perforated diverticular disease. Acetylsalicylic acid in cardiologic dose did not affect the rate of perforation (OR 0.66; 95% CI 0.27–1.61). The use of calcium channel blockers was associated with a reduced rate of diverticular complications (OR 0.14; 95% CI 0.02–0.95).

Conclusions

The administration of NSAIDs, opioids, and corticosteroids are associated with an increased risk of colonic diverticular perforation. Acetylsalicylic acid in cardiologic dose does not affect the risk of perforation. Calcium channel blockers are associated with a reduced risk of perforation.

Keywords

Diverticula Perforation Colon Risk factors 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Elliott TBYS, Irvin TT (1997) Five-year audit of the acute complications of diverticular disease. Br J Surg 84(4):535–539PubMedCrossRefGoogle Scholar
  2. 2.
    Chandra VNH, Larson DR, Harrington JR (2004) Impact of primary resection on the outcome of patients with perforated diverticulitis. Arch Surg 139(11):1221–1224PubMedCrossRefGoogle Scholar
  3. 3.
    Kriwanek SAC, Beckerhinn P, Dittrich K (1994) Prognostic factors for survival in colonic perforation. Int J Colorectal Dis 9(3):158–162PubMedCrossRefGoogle Scholar
  4. 4.
    Bielecki KKP, Klukowski M (2002) Large bowel perforation: morbidity and mortality. Tech Coloproctol 6(3):177–182PubMedCrossRefGoogle Scholar
  5. 5.
    Tudor RGFN, Keighley MRB (1994) National audit of complicated diverticular disease: analysis of index cases. Br J Surg 81:730–732PubMedCrossRefGoogle Scholar
  6. 6.
    Morris CRHI, Stebbings WSL, Speakman CTM, Kennedy HJ, Hart AR (2002) Epidemiology of perforated colonic diverticular disease. Postgrad Med J 78:654–659PubMedCrossRefGoogle Scholar
  7. 7.
    Morris CRHI, Stebbings WSL, Speakman CTM, Kennedy HJ, Hart AR (2003) Anti-inflammatory drugs, analgesics and the risk of perforated colonic diverticular disease. Br J Surg 90:1267–1272PubMedCrossRefGoogle Scholar
  8. 8.
    Wilson RGSA, Macintyre IMC (1990) Complications of diverticular disease and non-steroidal anti-inflammatory drugs: a prospective study. Br J Surg 77:1103–1104PubMedCrossRefGoogle Scholar
  9. 9.
    Goh HBR (2002) Non-steroidal anti-inflammatory drugs and perforated diverticular disease: a case control study. Ann R Coll Surg Engl 84:93–96PubMedGoogle Scholar
  10. 10.
    Yalouris AGRS (1987) Steroids, non-steroidal anti-inflammatory drugs, and serious septic complications of diverticular disease. Br Med J 295:1238CrossRefGoogle Scholar
  11. 11.
    Mpofu SMC, Hutchinson D, Maier AE, Dodd SR, Moots RJ (2004) Steroids, non-steroidal anti-inflammatory drugs, and sigmoid diverticular abscess perforation in rheumatic conditions. Ann Rheum Dis 63:588–590PubMedCrossRefGoogle Scholar
  12. 12.
    Aldori WHGE, Rimm EB, Wing AL, Willett WC (1998) Use of acetaminophen and nonsteroidal anti-inflammatory drugs: a prospective study and the risk of symptomatic diverticular disease in men. Arch Fam Med 7:255–260CrossRefGoogle Scholar
  13. 13.
    Langman MJSML, Worall A (1985) Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J 290:347–350Google Scholar
  14. 14.
    Schiffmann LKS, Berger G, Buhr HJ (2005) Colon perforation in an adolescent after short-term diclofenac intake. ANZ J Surg 75(8):726–727PubMedCrossRefGoogle Scholar
  15. 15.
    Durieux SRS, Bourgeois P (1999) Complications of colonic diverticular disease during rheumatoid polyarthritis: 7 cases. Rev Med Interne 20(1):50–53PubMedGoogle Scholar
  16. 16.
    EL A (1990) Corticosteroid-association perforation of colonic diverticula. Arch Intern Med 150(6):1337–1338CrossRefGoogle Scholar
  17. 17.
    Aloysius MMKP, Lobo DN (2006) Non-steroidal anti-inflammatory drug (NSAID)-induced colonic strictures and perforation: a case report. Dig Liver Dis 38(4):276–278PubMedCrossRefGoogle Scholar
  18. 18.
    Robinson MH, Wheatley T, Leach IH (1995) Nonsteroidal anti inflammatory drug-induced colonic stricture. An unusual cause of large bowel obstruction and perforation. Dig Dis Sci 40(2):315–319PubMedCrossRefGoogle Scholar
  19. 19.
    Candelas GJJ, Fernandez B, Rodriguez-Olaverri JC, Calatayud J (1998) Perforation of the sigmoid colon in a rheumatoid arthritis patient treated with methylprednisolone pulses. Scand J Rheumatol 27(2):152–153PubMedCrossRefGoogle Scholar
  20. 20.
    Dalla Valle RCE, Mazzoni MP, Busi N, Benozzi L, Sivelli R, Sianesi M (2005) Acute diverticulitis with colon perforation in renal transplantation. Transplant Proc 37(6):2507–2510PubMedCrossRefGoogle Scholar
  21. 21.
    Beaver TMFD, Zamora MR, Badesch DB, Weill D, Brown JM, Campbell DN, Grover FL (1996) Colon perforation after lung transplantation. Ann Thorac Surg 62(3):839–843PubMedCrossRefGoogle Scholar
  22. 22.
    Painter NSTS, Ardran GM, Tuckey M (1965) Effect of morphine, prostigmin, pethidine, and probanthine on the human colon in diverticulosis studied by intraluminal pressure recording and cineradiography. Gut 6:57–63PubMedCrossRefGoogle Scholar
  23. 23.
    Schang JCHM, Hebert M, Pilote M (1986) How does morphine work on colonic motility? An electromyographic study in the human left and sigmoid colon. Life Sci 38(8):671–676PubMedCrossRefGoogle Scholar
  24. 24.
    Frantzides CTCV, Salaymeh B, Tekin E, Condon RE (1992) Morphine effects on human colonic myoelectric activity in the postoperative period. Am J Surg 163(1):144–148PubMedCrossRefGoogle Scholar
  25. 25.
    Morris CRHI, Stebbings WSL, Speakman CTM, Kennedy HJ, Hart AR (2003) Do calcium channel blockers and antimuscarinics protect against perforated colonic diverticular disease? A case control study. Gut 52:1734–1737PubMedCrossRefGoogle Scholar
  26. 26.
    De Ponti FGC, Cosentino M, Lecchini S, Frigo G (1993) Calcium-channel blockers and gastrointestinal motility: basic and clinical aspects. Pharmacol Ther 60(1):121–148PubMedCrossRefGoogle Scholar
  27. 27.
    Bassotti GCC, Annese V, Fiorella S, Roselli P, Morelli A (1998) Nifedipine and verapamil inhibit the sigmoid colon myoelectric response to eating in healthy volunteers. Dis Colon Rectum 41(3):377–380PubMedCrossRefGoogle Scholar
  28. 28.
    Sun SGS, Kim DY, Schreiber TC, Schechner RS, Tellis VA (1997) Nifedipine protects small intestine from cyclosporine-induced hemodynamic and functional impairment. J Surg Res 69(2):295–299PubMedCrossRefGoogle Scholar
  29. 29.
    O’Brien MDCM, Thomforde GM et al (1997) Effect of cholecystokinin octapeptide and atropine on human colonic motility, tone, and transit. Dig Dis Sci 42:26–33PubMedCrossRefGoogle Scholar
  30. 30.
    Suchowiecky MCD, Bhasker M, Perry RJ, Snape WJ Jr (1987) Effect of secoverine on colonic myoelectric activity in diverticular disease of the colon. Dig Dis Sci 32(8):833–840PubMedCrossRefGoogle Scholar
  31. 31.
    Hansen OSW (1999) Divertikelerkrankung des Kolons—Stufenkonzept durch exakte Stadieneinteilung. Langenbecks Arch Chir Suppl II:1257–1260Google Scholar
  32. 32.
    Painter NSBD (1975) Diverticular disease of the colon, a 20th century problem. Clin Gastroenterol 4(1):3–21PubMedGoogle Scholar
  33. 33.
    Blachut KPL, Garcarek J (2004) Prevalence and distribution of the colonic diverticulosis. Review of 417 cases from Lower Silesia in Poland. Rom J Gastroenterol 13(4):281–285PubMedGoogle Scholar
  34. 34.
    Lanas ASP, Bajador E, Esteva F, Benito R, Sainz R (1997) Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology 112(3):683–689PubMedCrossRefGoogle Scholar
  35. 35.
    Campbell KSR (1991) Non-steroidal anti-inflammatory drugs and perforated diverticular disease: a case control study. Br J Surg 78:190–191PubMedCrossRefGoogle Scholar
  36. 36.
    Weiner HLRA, Cooper PR (1993) Sigmoid diverticular perforation in neurosurgical patients receiving high-dose corticosteroids. Neurosurgery 33:40–43PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  1. 1.Department of SurgerySundsvall HospitalSundsvallSweden
  2. 2.Department of Surgery and Perioperative ScienceUmeå UniversityUmeåSweden

Personalised recommendations